Study will use innovative technology to focus on neurodegenerative diseases
E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders
Modifying the huntingtin protein protected mice from cell death and motor impairment.
Get notified about new releases.
Sign up for email updates from Gladstone Institutes.
Notification Frequency